Fundraising Fox

Nutcracker Therapeutics

Emeryville, US · Founded 2017 · Delaware corporation · 3 known investors

nutcrackerx.com ↗
Biotech

Founders & leadership

IK
Igor KhandrosExecutive Officer, Director

Investors · 3

+ND CapitalWoodside · $540K – $5.4M
ARCH Venture PartnersChicago · $50K – $250Mvia Robert Nelsen · board
Bluebird VenturesPalo Altovia Jeffrey Bird · inferred

Reported raises · per SEC filings

Form D private placements
▶$144.5MraisedSep 2021 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert NelsenDirector
  • Benjamin EldridgeExecutive Officer
  • Madhavan BalachandranExecutive Officer
  • James ZhuExecutive Officer
  • Igor KhandrosExecutive Officer, Director
  • Samuel DeutschExecutive Officer
Offering amount
$200M
Amount sold
$144.5M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14MraisedMay 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert NelsenDirector
  • Igor KhandrosExecutive Officer, Director
Offering amount
$60M
Amount sold
$14M
First sale
May 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedMar 2019 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Igor KhandrosExecutive Officer, Director
Offering amount
$10.9M
Amount sold
$10M
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedMay 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Igor KhandrosExecutive Officer, Director
Offering amount
$4M
Amount sold
$4M
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.